Type and hit ENTER

News

All the posts published.

ProAxsis is delighted to have been shortlisted for a Business Eye First Trust Award for the second year running. Having been …

November 18, 2019

ProAxsis was delighted to support the recent School of Pharmacy Undergraduate Awards at Queen’s University, Belfast.  For the second year running, the …

October 25, 2019

ProAxsis is pleased to confirm that Professor Stephen Smith has become the Chairman of the company’s Board of Directors with immediate …

October 25, 2019

Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the British Lung Foundation (BLF) …

June 3, 2019

The potential benefits of ProAxsis’ novel ProteaseTag® Active Proteinase 3 Immunoassay will be discussed at the Winter meeting of the British Thoracic …

November 26, 2018

ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …

September 20, 2018

ProAxsis Limited (www.proaxsis.com), the Belfast-based company focused on developing new assays for the measurement of active protease biomarkers of disease, today announces …

August 2, 2018

ProAxsis Limited has been declared as the “Innovative Business of the Year” at the Business Eye First Trust Awards (BEFTAs) for …

June 4, 2018

ProAxsis Limited has received an Invest NI Grant for Research and Development, supporting the company to develop new products using its innovative …

June 1, 2018

ProAxsis is proud to be collaborating with Dr. Gunnar Schroeder and Prof. Cliff Taggart from the School of Medicine, Dentistry and …

March 6, 2018
News Archives | ProAxsis